Long-Term Effects of Torso-Weighting

NCT02743312 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2018-11-06

Study results available
· View outcomes & findings →

Summary

The goal of this pilot study is to test the protocol for investigating the longer-term effects of torso weighting on physical activity, number of falls, and muscle activation (when muscles turn on and off and how intensely) in five volunteers with multiple sclerosis. The hypotheses of this study include: torso weighting will (1) increase physical activity, (2) decrease the number of falls, and (3) improve the timing and coordination of muscle activation during balance perturbations.

Conditions

Interventions

DEVICE

Torso Weights

Following assessment of an individual's directional instability, small weights are applied to a vest-like garment to correct balance loss.

DEVICE

Sham Weights

Following assessment of an individual's directional instability, small weights are applied to a vest-like garment to correct balance loss. The garment is then taken by another investigator and the actual weights are replaced with sham weights.

DEVICE

Fitbit Flex

Potential effect on participants' physical activity to see their own step count using this wrist-worn remote monitoring device.

Sponsors & Collaborators

  • Samuel Merritt University

    collaborator OTHER
  • San Francisco State University

    lead OTHER

Principal Investigators

  • Diane Allen, PhD · San Francisco State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-05-31
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02743312 on ClinicalTrials.gov